{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:15:43Z","timestamp":1775063743661,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2023SF50"],"award-info":[{"award-number":["2023SF50"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022CR38"],"award-info":[{"award-number":["2022CR38"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00792-z","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:51:38Z","timestamp":1756407098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative outcome and prognostic factor analysis among MDS\/AML patients with TP53 mutations, snps, and wild type"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaodi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Wuchty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"792_CR1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1200\/JCO.2016.71.2208","volume":"35","author":"L Bullinger","year":"2017","unstructured":"Bullinger L, D\u00f6hner K, D\u00f6hner H. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 2017;35:934\u201346.","journal-title":"J Clin Oncol"},{"key":"792_CR2","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122:3616\u201327.","journal-title":"Blood"},{"key":"792_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"792_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner H, Estey EH, Amadori S, Appelbaum FR, B\u00fcchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453\u201374.","journal-title":"Blood"},{"key":"792_CR5","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1002\/cncr.30203","volume":"122","author":"TM Kadia","year":"2016","unstructured":"Kadia TM, Jain P, Ravandi F, Garcia-Manero G, Andreef M, Takahashi K, et al. TP53 mutations in newly diagnosed acute myeloid leukemia: clinicomolecular characteristics, response to therapy, and outcomes. Cancer. 2016;122:3484\u201391.","journal-title":"Cancer"},{"key":"792_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ajh.25469","volume":"94","author":"GMK Leung","year":"2019","unstructured":"Leung GMK, Zhang C, Ng NKL, Yang N, Lam SSY, Au CH, et al. Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex\/monosomy karyotype acute myeloid leukemia carrying TP53 mutations. Am J Hematol. 2019;94:650\u20137.","journal-title":"Am J Hematol"},{"key":"792_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc.2017.109","volume":"18","author":"VJN Bykov","year":"2018","unstructured":"Bykov VJN, Eriksson SE, Bianchi J, Wiman KG. Targeting mutant p53 for efficient cancer therapy. Nat Rev Cancer. 2018;18:89\u2013102.","journal-title":"Nat Rev Cancer"},{"key":"792_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200\u201328.","journal-title":"Blood"},{"key":"792_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1056\/NEJMoa1611604","volume":"376","author":"RC Lindsley","year":"2017","unstructured":"Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med. 2017;376:536\u201347.","journal-title":"N Engl J Med"},{"key":"792_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1182\/blood-2017-02-763086","volume":"130","author":"M Prokocimer","year":"2017","unstructured":"Prokocimer M, Molchadsky A, Rotter V. Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy. Blood. 2017;130:699\u2013712.","journal-title":"Blood"},{"key":"792_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","volume":"128","author":"KH Metzeler","year":"2016","unstructured":"Metzeler KH, Herold T, Rothenberg-Thurley M, Amler S, Sauerland MC, G\u00f6rlich D, et al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood. 2016;128:686\u201398.","journal-title":"Blood"},{"key":"792_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/leu.2016.263","volume":"31","author":"A Stengel","year":"2017","unstructured":"Stengel A, Kern W, Haferlach T, Meggendorfer M, Fasan A, Haferlach C. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases. Leukemia. 2017;31:705\u201311.","journal-title":"Leukemia"},{"key":"792_CR13","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390.","journal-title":"Bioinformatics"},{"key":"792_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kerntsky A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"792_CR15","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.","journal-title":"Nucleic Acids Res"},{"key":"792_CR16","doi-asserted-by":"publisher","first-page":"D648","DOI":"10.1093\/nar\/gkab1006","volume":"50","author":"N Del Toro","year":"2022","unstructured":"Del Toro N, Shrivastava A, Ragueneau E, Meldal B, Combe C, Barrera E, et al. The IntAct database: efficient access to fine-grained molecular interaction data. Nucleic Acids Res. 2022;50:D648\u201353.","journal-title":"Nucleic Acids Res"},{"key":"792_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CWV. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.","journal-title":"BMC Bioinformatics"},{"key":"792_CR18","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"792_CR19","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"The Gene Ontology Consortium","year":"2019","unstructured":"The Gene Ontology Consortium. The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330\u20138.","journal-title":"Nucleic Acids Res"},{"key":"792_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"792_CR21","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.7314\/APJCP.2014.15.4.1603","volume":"15","author":"SB Zeichner","year":"2014","unstructured":"Zeichner SB, Alghamdi S, Elhammady G, Poppiti RJ. Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review. Asian Pac J Cancer Prev. 2014;15:1603\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"792_CR22","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/jnci\/djab019","volume":"113","author":"C De Souza","year":"2021","unstructured":"De Souza C, Madden J, Koestler DC, Minn D, Montoya DJ, Minn K, et al. Effect of the p53 P72R polymorphism on mutant TP53 allele selection in human Cancer. J Natl Cancer Inst. 2021;113:1246\u201357.","journal-title":"J Natl Cancer Inst"},{"key":"792_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.omtn.2022.07.014","volume":"29","author":"M Kang","year":"2022","unstructured":"Kang M, Kharbash R, Byun JM, Jeon J, Ali AA, Ku D, et al. Double-stranded RNA induction as a potential dynamic biomarkerfor DNA-demethylating agents. Mol Ther Nucleic Acids. 2022;29:370\u201383.","journal-title":"Mol Ther Nucleic Acids"},{"key":"792_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/emboj.2012.357","volume":"32","author":"R Deplus","year":"2013","unstructured":"Deplus R, Delatte B, Schwinn MK, Defrance M, M\u00e9ndez J, Murphy N, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1\/COMPASS. EMBO J. 2013;32:645\u201355.","journal-title":"EMBO J"},{"key":"792_CR25","doi-asserted-by":"publisher","first-page":"e1006518","DOI":"10.1371\/journal.ppat.1006518","volume":"13","author":"D Groussaud","year":"2017","unstructured":"Groussaud D, Khair M, Tollenaere AI, Waast L, Kuo MS, Mangeney M, et al. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription. PLoS Pathog. 2017;13:e1006518.","journal-title":"PLoS Pathog"},{"key":"792_CR26","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41388-022-02340-8","volume":"41","author":"D Li","year":"2022","unstructured":"Li D, Yu X, Kottur J, Gong W, Zhang Z, Storey AJ, et al. Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic. Oncogene. 2022;41:3328\u201340.","journal-title":"Oncogene"},{"key":"792_CR27","doi-asserted-by":"publisher","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","volume":"50","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang Y, Lian X, Li F, Wang C, Zhu F, et al. Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Res. 2022;50:D1398\u2013407.","journal-title":"Nucleic Acids Res"},{"key":"792_CR28","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1021\/acs.jmedchem.2c00195","volume":"65","author":"KB Teuscher","year":"2022","unstructured":"Teuscher KB, Meyers KM, Wei Q, Mills JJ, Tian J, Alvarado J, et al. Discovery of potent orally bioavailable WD repeat domain 5 (WDR5) inhibitors using a pharmacophore-based optimization. J Med Chem. 2022;65:6287\u2013312.","journal-title":"J Med Chem"},{"key":"792_CR29","doi-asserted-by":"publisher","first-page":"102678","DOI":"10.1016\/j.ebiom.2020.102678","volume":"54","author":"KM Kampa-Schittenhelm","year":"2020","unstructured":"Kampa-Schittenhelm KM, Haverkamp T, Bonin M, Tsintari V, B\u00fchring HJ, Haeusser L, et al. Epigenetic activation of O-linked \u03b2-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia. EBioMedicine. 2020;54:102678.","journal-title":"EBioMedicine"},{"key":"792_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.str.2010.09.022","volume":"19","author":"V Avdic","year":"2011","unstructured":"Avdic V, Zhang P, Lanouette S, Groulx A, Tremblay V, Brunzelle J, et al. Structural and biochemical insights into MLL1 core complex assembly. Structure. 2011;19:101\u20138.","journal-title":"Structure"},{"key":"792_CR31","doi-asserted-by":"publisher","first-page":"24242","DOI":"10.1074\/jbc.M109.014498","volume":"284","author":"A Patel","year":"2009","unstructured":"Patel A, Dharmarajan V, Vought VE, Cosgrove MS. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex. J Biol Chem. 2009;284:24242\u201356.","journal-title":"J Biol Chem"},{"key":"792_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1212\/01.wnl.0000341277.74885.ec","volume":"72","author":"S Hallani","year":"2009","unstructured":"Hallani S, El, Ducray F, Idbaih A, Marie Y, Boisselier B, Colin C, et al. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology. 2009;72:332\u20136.","journal-title":"Neurology"},{"key":"792_CR33","doi-asserted-by":"crossref","unstructured":"Dumont P, Leu JIJ, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357\u201365.","DOI":"10.1038\/ng1093"},{"key":"792_CR34","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1074\/jbc.M008879200","volume":"276","author":"M Berger","year":"2001","unstructured":"Berger M, Sionov RV, Levine AJ, Haupt Y. A role for the polyproline domain of p53 in its regulation by Mdm2. J Biol Chem. 2001;276:3785\u201390.","journal-title":"J Biol Chem"},{"key":"792_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun L, Sonkin D, Ardin M, Hollstein M, Byrnes G, Zavadil J, et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37:865\u201376.","journal-title":"Hum Mutat"},{"key":"792_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.molcel.2018.06.012","volume":"71","author":"E Kotler","year":"2018","unstructured":"Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, et al. A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation. Mol Cell. 2018;71:178\u201390.","journal-title":"Mol Cell"},{"key":"792_CR37","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1431692100","volume":"100","author":"S Kato","year":"2003","unstructured":"Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A. 2003;100:8424\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"792_CR38","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","volume":"6","author":"OK Weinberg","year":"2022","unstructured":"Weinberg OK, Siddon A, Madanat YF, Gagan J, Arber DA, Cin PD, et al. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML. Blood Adv. 2022;6:2847\u201353.","journal-title":"Blood Adv"},{"key":"792_CR39","doi-asserted-by":"crossref","unstructured":"Huang T, Xu L, Zhang X, Chang Y, Mo X, Sun Y et al. Haploidentical Haematopoietic stem cell transplantation for TP53-mutated acute myeloid leukaemia. Br J Haematol. 2023;200:494\u2013505.","DOI":"10.1111\/bjh.18538"},{"key":"792_CR40","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1182\/bloodadvances.2020003120","volume":"4","author":"NJ Short","year":"2020","unstructured":"Short NJ, Montalban-Bravo G, Hwang H, Ning J, Franquiz MJ, Kanagal-Shamanna R, et al. Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia. Blood Adv. 2020;4:5681\u20139.","journal-title":"Blood Adv"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00792-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:25:36Z","timestamp":1757485536000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00792-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00792-z","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study followed the rules of the Helsinki Declaration and received approval from the Biomedical Research Ethics Committee, Peking University First Hospital (No. 2023yan101-002). All patients signed informed consent forms for inclusion in the clinical trial and genetic analyses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication of the present manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}